img

Global Friedreich Ataxia Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Friedreich Ataxia Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Friedreich Ataxia Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Friedreich Ataxia Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Friedreich Ataxia Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Friedreich Ataxia Drug key manufacturers include Adverum Biotechnologies Inc, BioMarin Pharmaceutical Inc., Biovista Inc., Cardero Therapeutics Inc, Catabasis Pharmaceuticals, Inc., Forward Pharma A/S, Ixchel Pharma LLC, Pfizer Inc and ProQR Therapeutics NV, etc. Adverum Biotechnologies Inc, BioMarin Pharmaceutical Inc., Biovista Inc. are top 3 players and held % sales share in total in 2022.
Friedreich Ataxia Drug can be divided into ADVM-063, AGIL-FA, BHV-4157 and BVA-202, etc. ADVM-063 is the mainstream product in the market, accounting for % sales share globally in 2022.
Friedreich Ataxia Drug is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Friedreich Ataxia Drug industry development. In 2022, global % sales of Friedreich Ataxia Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Friedreich Ataxia Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Takeda
STATegics Inc
Voyager Therapeutics Inc
Segment by Type
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others

Segment by Application


Clinic
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Friedreich Ataxia Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Friedreich Ataxia Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Friedreich Ataxia Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Friedreich Ataxia Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Friedreich Ataxia Drug introduction, etc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Friedreich Ataxia Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Friedreich Ataxia Drug Market Overview
1.1 Friedreich Ataxia Drug Product Overview
1.2 Friedreich Ataxia Drug Market Segment by Type
1.2.1 ADVM-063
1.2.2 AGIL-FA
1.2.3 BHV-4157
1.2.4 BVA-202
1.2.5 Others
1.3 Global Friedreich Ataxia Drug Market Size by Type
1.3.1 Global Friedreich Ataxia Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Friedreich Ataxia Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Friedreich Ataxia Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Friedreich Ataxia Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Friedreich Ataxia Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Friedreich Ataxia Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Friedreich Ataxia Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Friedreich Ataxia Drug Sales Breakdown by Type (2018-2024)
2 Global Friedreich Ataxia Drug Market Competition by Company
2.1 Global Top Players by Friedreich Ataxia Drug Sales (2018-2024)
2.2 Global Top Players by Friedreich Ataxia Drug Revenue (2018-2024)
2.3 Global Top Players by Friedreich Ataxia Drug Price (2018-2024)
2.4 Global Top Manufacturers Friedreich Ataxia Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Friedreich Ataxia Drug Market Competitive Situation and Trends
2.5.1 Friedreich Ataxia Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Friedreich Ataxia Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Friedreich Ataxia Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Friedreich Ataxia Drug Market
2.8 Key Manufacturers Friedreich Ataxia Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Friedreich Ataxia Drug Status and Outlook by Region
3.1 Global Friedreich Ataxia Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Friedreich Ataxia Drug Historic Market Size by Region
3.2.1 Global Friedreich Ataxia Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Friedreich Ataxia Drug Sales in Value by Region (2018-2024)
3.2.3 Global Friedreich Ataxia Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Friedreich Ataxia Drug Forecasted Market Size by Region
3.3.1 Global Friedreich Ataxia Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Friedreich Ataxia Drug Sales in Value by Region (2024-2034)
3.3.3 Global Friedreich Ataxia Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Friedreich Ataxia Drug by Application
4.1 Friedreich Ataxia Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Friedreich Ataxia Drug Market Size by Application
4.2.1 Global Friedreich Ataxia Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Friedreich Ataxia Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Friedreich Ataxia Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Friedreich Ataxia Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Friedreich Ataxia Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Friedreich Ataxia Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Friedreich Ataxia Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Friedreich Ataxia Drug Sales Breakdown by Application (2018-2024)
5 North America Friedreich Ataxia Drug by Country
5.1 North America Friedreich Ataxia Drug Historic Market Size by Country
5.1.1 North America Friedreich Ataxia Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Friedreich Ataxia Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Friedreich Ataxia Drug Sales in Value by Country (2018-2024)
5.2 North America Friedreich Ataxia Drug Forecasted Market Size by Country
5.2.1 North America Friedreich Ataxia Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Friedreich Ataxia Drug Sales in Value by Country (2024-2034)
6 Europe Friedreich Ataxia Drug by Country
6.1 Europe Friedreich Ataxia Drug Historic Market Size by Country
6.1.1 Europe Friedreich Ataxia Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Friedreich Ataxia Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Friedreich Ataxia Drug Sales in Value by Country (2018-2024)
6.2 Europe Friedreich Ataxia Drug Forecasted Market Size by Country
6.2.1 Europe Friedreich Ataxia Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Friedreich Ataxia Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Friedreich Ataxia Drug by Region
7.1 Asia-Pacific Friedreich Ataxia Drug Historic Market Size by Region
7.1.1 Asia-Pacific Friedreich Ataxia Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Friedreich Ataxia Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Friedreich Ataxia Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Friedreich Ataxia Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Friedreich Ataxia Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Friedreich Ataxia Drug Sales in Value by Region (2024-2034)
8 Latin America Friedreich Ataxia Drug by Country
8.1 Latin America Friedreich Ataxia Drug Historic Market Size by Country
8.1.1 Latin America Friedreich Ataxia Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Friedreich Ataxia Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Friedreich Ataxia Drug Sales in Value by Country (2018-2024)
8.2 Latin America Friedreich Ataxia Drug Forecasted Market Size by Country
8.2.1 Latin America Friedreich Ataxia Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Friedreich Ataxia Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Friedreich Ataxia Drug by Country
9.1 Middle East and Africa Friedreich Ataxia Drug Historic Market Size by Country
9.1.1 Middle East and Africa Friedreich Ataxia Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Friedreich Ataxia Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Friedreich Ataxia Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Friedreich Ataxia Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Friedreich Ataxia Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Friedreich Ataxia Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Adverum Biotechnologies Inc
10.1.1 Adverum Biotechnologies Inc Company Information
10.1.2 Adverum Biotechnologies Inc Introduction and Business Overview
10.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products Offered
10.1.5 Adverum Biotechnologies Inc Recent Development
10.2 BioMarin Pharmaceutical Inc.
10.2.1 BioMarin Pharmaceutical Inc. Company Information
10.2.2 BioMarin Pharmaceutical Inc. Introduction and Business Overview
10.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Products Offered
10.2.5 BioMarin Pharmaceutical Inc. Recent Development
10.3 Biovista Inc.
10.3.1 Biovista Inc. Company Information
10.3.2 Biovista Inc. Introduction and Business Overview
10.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biovista Inc. Friedreich Ataxia Drug Products Offered
10.3.5 Biovista Inc. Recent Development
10.4 Cardero Therapeutics Inc
10.4.1 Cardero Therapeutics Inc Company Information
10.4.2 Cardero Therapeutics Inc Introduction and Business Overview
10.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Products Offered
10.4.5 Cardero Therapeutics Inc Recent Development
10.5 Catabasis Pharmaceuticals, Inc.
10.5.1 Catabasis Pharmaceuticals, Inc. Company Information
10.5.2 Catabasis Pharmaceuticals, Inc. Introduction and Business Overview
10.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Products Offered
10.5.5 Catabasis Pharmaceuticals, Inc. Recent Development
10.6 Forward Pharma A/S
10.6.1 Forward Pharma A/S Company Information
10.6.2 Forward Pharma A/S Introduction and Business Overview
10.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Forward Pharma A/S Friedreich Ataxia Drug Products Offered
10.6.5 Forward Pharma A/S Recent Development
10.7 Ixchel Pharma LLC
10.7.1 Ixchel Pharma LLC Company Information
10.7.2 Ixchel Pharma LLC Introduction and Business Overview
10.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Products Offered
10.7.5 Ixchel Pharma LLC Recent Development
10.8 Pfizer Inc
10.8.1 Pfizer Inc Company Information
10.8.2 Pfizer Inc Introduction and Business Overview
10.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer Inc Friedreich Ataxia Drug Products Offered
10.8.5 Pfizer Inc Recent Development
10.9 ProQR Therapeutics NV
10.9.1 ProQR Therapeutics NV Company Information
10.9.2 ProQR Therapeutics NV Introduction and Business Overview
10.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Products Offered
10.9.5 ProQR Therapeutics NV Recent Development
10.10 RaNA Therapeutics Inc
10.10.1 RaNA Therapeutics Inc Company Information
10.10.2 RaNA Therapeutics Inc Introduction and Business Overview
10.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Products Offered
10.10.5 RaNA Therapeutics Inc Recent Development
10.11 Reata Pharmaceuticals Inc
10.11.1 Reata Pharmaceuticals Inc Company Information
10.11.2 Reata Pharmaceuticals Inc Introduction and Business Overview
10.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Products Offered
10.11.5 Reata Pharmaceuticals Inc Recent Development
10.12 Retrotope Inc
10.12.1 Retrotope Inc Company Information
10.12.2 Retrotope Inc Introduction and Business Overview
10.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Retrotope Inc Friedreich Ataxia Drug Products Offered
10.12.5 Retrotope Inc Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Takeda Friedreich Ataxia Drug Products Offered
10.13.5 Takeda Recent Development
10.14 STATegics Inc
10.14.1 STATegics Inc Company Information
10.14.2 STATegics Inc Introduction and Business Overview
10.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 STATegics Inc Friedreich Ataxia Drug Products Offered
10.14.5 STATegics Inc Recent Development
10.15 Voyager Therapeutics Inc
10.15.1 Voyager Therapeutics Inc Company Information
10.15.2 Voyager Therapeutics Inc Introduction and Business Overview
10.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Products Offered
10.15.5 Voyager Therapeutics Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Friedreich Ataxia Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Friedreich Ataxia Drug Industrial Chain Analysis
11.4 Friedreich Ataxia Drug Market Dynamics
11.4.1 Friedreich Ataxia Drug Industry Trends
11.4.2 Friedreich Ataxia Drug Market Drivers
11.4.3 Friedreich Ataxia Drug Market Challenges
11.4.4 Friedreich Ataxia Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Friedreich Ataxia Drug Distributors
12.3 Friedreich Ataxia Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ADVM-063
Table 2. Major Company of AGIL-FA
Table 3. Major Company of BHV-4157
Table 4. Major Company of BVA-202
Table 5. Major Company of Others
Table 6. Global Friedreich Ataxia Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Friedreich Ataxia Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Friedreich Ataxia Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Friedreich Ataxia Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Friedreich Ataxia Drug Market Share in Value by Type (2018-2024)
Table 11. Global Friedreich Ataxia Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Friedreich Ataxia Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Friedreich Ataxia Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Friedreich Ataxia Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Friedreich Ataxia Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Friedreich Ataxia Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Friedreich Ataxia Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Friedreich Ataxia Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Friedreich Ataxia Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Friedreich Ataxia Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Friedreich Ataxia Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Friedreich Ataxia Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Friedreich Ataxia Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Friedreich Ataxia Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Friedreich Ataxia Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Friedreich Ataxia Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Friedreich Ataxia Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Friedreich Ataxia Drug Sales Share by Company (2018-2024)
Table 29. Global Friedreich Ataxia Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Friedreich Ataxia Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Friedreich Ataxia Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Friedreich Ataxia Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Friedreich Ataxia Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Friedreich Ataxia Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Friedreich Ataxia Drug Market
Table 36. Key Manufacturers Friedreich Ataxia Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Friedreich Ataxia Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Friedreich Ataxia Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Friedreich Ataxia Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Friedreich Ataxia Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Friedreich Ataxia Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Friedreich Ataxia Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Friedreich Ataxia Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Friedreich Ataxia Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Friedreich Ataxia Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Friedreich Ataxia Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Friedreich Ataxia Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Friedreich Ataxia Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Friedreich Ataxia Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Friedreich Ataxia Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Friedreich Ataxia Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Friedreich Ataxia Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Friedreich Ataxia Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Friedreich Ataxia Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Friedreich Ataxia Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Friedreich Ataxia Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Friedreich Ataxia Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Friedreich Ataxia Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Friedreich Ataxia Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Friedreich Ataxia Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Friedreich Ataxia Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Friedreich Ataxia Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Friedreich Ataxia Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Friedreich Ataxia Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Friedreich Ataxia Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Friedreich Ataxia Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Friedreich Ataxia Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Friedreich Ataxia Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Friedreich Ataxia Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Friedreich Ataxia Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Friedreich Ataxia Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Friedreich Ataxia Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Friedreich Ataxia Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Friedreich Ataxia Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Friedreich Ataxia Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Friedreich Ataxia Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Friedreich Ataxia Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Friedreich Ataxia Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Friedreich Ataxia Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Friedreich Ataxia Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Friedreich Ataxia Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Friedreich Ataxia Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Friedreich Ataxia Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Friedreich Ataxia Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Friedreich Ataxia Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Friedreich Ataxia Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Friedreich Ataxia Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Friedreich Ataxia Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Friedreich Ataxia Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Friedreich Ataxia Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Friedreich Ataxia Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Friedreich Ataxia Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Friedreich Ataxia Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Friedreich Ataxia Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Adverum Biotechnologies Inc Company Information
Table 111. Adverum Biotechnologies Inc Introduction and Business Overview
Table 112. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product
Table 114. Adverum Biotechnologies Inc Recent Development
Table 115. BioMarin Pharmaceutical Inc. Company Information
Table 116. BioMarin Pharmaceutical Inc. Introduction and Business Overview
Table 117. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product
Table 119. BioMarin Pharmaceutical Inc. Recent Development
Table 120. Biovista Inc. Company Information
Table 121. Biovista Inc. Introduction and Business Overview
Table 122. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Biovista Inc. Friedreich Ataxia Drug Product
Table 124. Biovista Inc. Recent Development
Table 125. Cardero Therapeutics Inc Company Information
Table 126. Cardero Therapeutics Inc Introduction and Business Overview
Table 127. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Cardero Therapeutics Inc Friedreich Ataxia Drug Product
Table 129. Cardero Therapeutics Inc Recent Development
Table 130. Catabasis Pharmaceuticals, Inc. Company Information
Table 131. Catabasis Pharmaceuticals, Inc. Introduction and Business Overview
Table 132. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product
Table 134. Catabasis Pharmaceuticals, Inc. Recent Development
Table 135. Forward Pharma A/S Company Information
Table 136. Forward Pharma A/S Introduction and Business Overview
Table 137. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Forward Pharma A/S Friedreich Ataxia Drug Product
Table 139. Forward Pharma A/S Recent Development
Table 140. Ixchel Pharma LLC Company Information
Table 141. Ixchel Pharma LLC Introduction and Business Overview
Table 142. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Ixchel Pharma LLC Friedreich Ataxia Drug Product
Table 144. Ixchel Pharma LLC Recent Development
Table 145. Pfizer Inc Company Information
Table 146. Pfizer Inc Introduction and Business Overview
Table 147. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Pfizer Inc Friedreich Ataxia Drug Product
Table 149. Pfizer Inc Recent Development
Table 150. ProQR Therapeutics NV Company Information
Table 151. ProQR Therapeutics NV Introduction and Business Overview
Table 152. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. ProQR Therapeutics NV Friedreich Ataxia Drug Product
Table 154. ProQR Therapeutics NV Recent Development
Table 155. RaNA Therapeutics Inc Company Information
Table 156. RaNA Therapeutics Inc Introduction and Business Overview
Table 157. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. RaNA Therapeutics Inc Friedreich Ataxia Drug Product
Table 159. RaNA Therapeutics Inc Recent Development
Table 160. Reata Pharmaceuticals Inc Company Information
Table 161. Reata Pharmaceuticals Inc Introduction and Business Overview
Table 162. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product
Table 164. Reata Pharmaceuticals Inc Recent Development
Table 165. Retrotope Inc Company Information
Table 166. Retrotope Inc Introduction and Business Overview
Table 167. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Retrotope Inc Friedreich Ataxia Drug Product
Table 169. Retrotope Inc Recent Development
Table 170. Takeda Company Information
Table 171. Takeda Introduction and Business Overview
Table 172. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. Takeda Friedreich Ataxia Drug Product
Table 174. Takeda Recent Development
Table 175. STATegics Inc Company Information
Table 176. STATegics Inc Introduction and Business Overview
Table 177. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. STATegics Inc Friedreich Ataxia Drug Product
Table 179. STATegics Inc Recent Development
Table 180. Voyager Therapeutics Inc Company Information
Table 181. Voyager Therapeutics Inc Introduction and Business Overview
Table 182. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 183. Voyager Therapeutics Inc Friedreich Ataxia Drug Product
Table 184. Voyager Therapeutics Inc Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Friedreich Ataxia Drug Market Trends
Table 188. Friedreich Ataxia Drug Market Drivers
Table 189. Friedreich Ataxia Drug Market Challenges
Table 190. Friedreich Ataxia Drug Market Restraints
Table 191. Friedreich Ataxia Drug Distributors List
Table 192. Friedreich Ataxia Drug Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Friedreich Ataxia Drug Product Picture
Figure 2. Global Friedreich Ataxia Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Friedreich Ataxia Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Friedreich Ataxia Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ADVM-063
Figure 6. Global ADVM-063 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of AGIL-FA
Figure 8. Global AGIL-FA Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of BHV-4157
Figure 10. Global BHV-4157 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of BVA-202
Figure 12. Global BVA-202 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Friedreich Ataxia Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Friedreich Ataxia Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Friedreich Ataxia Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Friedreich Ataxia Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Friedreich Ataxia Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Friedreich Ataxia Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Friedreich Ataxia Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Friedreich Ataxia Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Friedreich Ataxia Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Friedreich Ataxia Drug Revenue in 2022
Figure 29. Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Friedreich Ataxia Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Friedreich Ataxia Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Friedreich Ataxia Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Friedreich Ataxia Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Friedreich Ataxia Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Friedreich Ataxia Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Friedreich Ataxia Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Friedreich Ataxia Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Friedreich Ataxia Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Friedreich Ataxia Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Friedreich Ataxia Drug Manufacturing Cost Structure
Figure 49. Friedreich Ataxia Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries